- Home
- EXLS vs HALO Comparison
EXLS vs HALO Comparison
Compare EXLS & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXLS
- HALO
- Stock Information
- Founded
- EXLS 1999
- HALO 1998
- Country
- EXLS United States
- HALO United States
- Employees
- EXLS N/A
- HALO N/A
- Industry
- EXLS Business Services
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EXLS Consumer Discretionary
- HALO Health Care
- Exchange
- EXLS Nasdaq
- HALO Nasdaq
- Market Cap
- EXLS 7.0B
- HALO 7.4B
- IPO Year
- EXLS 2006
- HALO N/A
- Fundamental
- Price
- EXLS $45.58
- HALO $54.54
- Analyst Decision
- EXLS Strong Buy
- HALO Buy
- Analyst Count
- EXLS 7
- HALO 9
- Target Price
- EXLS $50.29
- HALO $63.56
- AVG Volume (30 Days)
- EXLS 1.5M
- HALO 3.3M
- Earning Date
- EXLS 04-29-2025
- HALO 05-06-2025
- Dividend Yield
- EXLS N/A
- HALO N/A
- EPS Growth
- EXLS 21.21
- HALO 55.40
- EPS
- EXLS 1.32
- HALO 3.76
- Revenue
- EXLS $1,902,884,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- EXLS $14.18
- HALO $25.77
- Revenue Next Year
- EXLS $11.53
- HALO $18.01
- P/E Ratio
- EXLS $34.48
- HALO $14.51
- Revenue Growth
- EXLS 14.18
- HALO 25.64
- 52 Week Low
- EXLS $28.59
- HALO $42.01
- 52 Week High
- EXLS $52.43
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- EXLS 47.63
- HALO 44.48
- Support Level
- EXLS $45.65
- HALO $52.43
- Resistance Level
- EXLS $46.48
- HALO $54.26
- Average True Range (ATR)
- EXLS 0.96
- HALO 3.42
- MACD
- EXLS -0.05
- HALO -0.49
- Stochastic Oscillator
- EXLS 18.35
- HALO 30.60
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.